U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

  • This publication is provided for historical reference only and the information may be out of date.

This publication is provided for historical reference only and the information may be out of date.

Cover of Guidelines for the Management of Transfusion Dependent Thalassaemia (TDT)

Guidelines for the Management of Transfusion Dependent Thalassaemia (TDT), 3rd edition

Editors: Maria Domenica Cappellini, Alan Cohen, John Porter, Ali Taher, and Vip Viprakasit.

Editor Information
Nicosia (CY): Thalassaemia International Federation; .
ISBN-13: 978-9963-717-06-4

The full costs of treating patients with inherited disorders of haemoglobin is extremely variable among countries depending on different health care systems, varying methods of obtaining blood, different practices in screening for blood pathogens and different costs of drugs and equipment. It is evident that all countries would benefit from the sharing of experience and expertise in order to harmonize and optimize the quality of treatment as much as possible. The need for management guidelines for Transfusion Dependent Thalassaemias (TDT) is clear. Throughout the past four years, six major TDT management guidelines became available for use by thalassaemia care givers (TIF, US, Canadian, UK, Italian and Australian Guidelines). A comparison among those guidelines has been recently published (Musallam KM et al. Acta Haematologica 2013). In light of a swiftly evolving evidence, the need for revisiting and updating TDT management recommendations remains crucial. More importantly, ensuring access to such guidelines and careful application and implementation should only help arriving at early diagnosis of morbidity to allow prompt and effective management. It would also allow early prediction of risk and would enable preventive measures to be set in place saving unnecessary health care costs.

This updated third edition of the TIF guidelines will offer valuable information to all allied healthcare professionals involved in the treatment of patients with TDT. It includes updated information on new approaches for more effective, safe and less laborious treatment, and an overview of the progress achieved to date towards a total cure using methods such as gene therapy and stem cell transplantation.

Contents

“Cure sometimes, treat often, comfort always.”

Hippocrates (460-357 B.C.)

“The good physician treats the disease; the great physician treats the patient who has the disease.”

Sir William Osler (1849-1919)

© 2014 Thalassaemia International Federation.

All rights reserved.

No part of this book may be reproduced, stored in a retrieval system, or transmitted in any from or by any means, electronic, mechanical, photocopying, microfilming, recording or otherwise, without written permission from TIF.

Bookshelf ID: NBK269382PMID: 25610943

Views

  • PubReader
  • Print View
  • Cite this Page

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...